FDA Approved: AMPICILLIN AND SULBACTAM — Supplemental Application (Hospira, Inc)

View source ↗

Summary

FDA approved a supplemental application for ampicillin/sulbactam from Hospira for the existing product (Unasyn).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Infection
• Intra-abdominal Infection
• Lower Respiratory Tract Infection
• Skin and Skin Structure Infections

Drugs mentioned

• UNASYN (Ampicillin sodium and sulbactam sodium)

Snippet

SUPPL AP for AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM AND SULBACTAM SODIUM)